documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

48 rows where docket_id = "FDA-1996-N-0006" and posted_year = 2009 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: posted_date, posted_month, comment_start_date, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 2

posted_year 1

  • 2009 · 48 ✖

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1996-N-0006-0067 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Keller and Heckman, LLP, May 4, 2009 Other Letter(s) 2009-05-05T04:00:00Z 2009 5 2009-05-05T04:00:00Z   2015-05-05T18:56:47Z   0 0 0900006480975db3
FDA-1996-N-0006-0076 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Buchanan Ingersoll, May 4, 2009 Other Letter(s) 2009-05-05T04:00:00Z 2009 5 2009-05-05T04:00:00Z   2015-05-05T19:26:22Z   0 0 090000648097603e
FDA-1996-N-0006-0070 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Morgan, Lewis & Bockius, LLP, May 4, 2009 Other Letter(s) 2009-05-05T04:00:00Z 2009 5 2009-05-05T04:00:00Z   2015-05-05T19:09:46Z   0 0 0900006480976038
FDA-1996-N-0006-0065 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Steinberg & Associates, Inc., May 4, 2009 Other Letter(s) 2009-05-05T04:00:00Z 2009 5 2009-05-05T04:00:00Z   2015-05-05T18:48:08Z   0 0 0900006480975db0
FDA-1996-N-0006-0068 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to The Personal Care Products Council, May 4, 2009 Other Letter(s) 2009-05-05T04:00:00Z 2009 5 2009-05-05T04:00:00Z   2015-05-05T18:59:39Z   0 0 0900006480975db4
FDA-1996-N-0006-0075 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter From FDA/CDER Division of Nonprescription Regulation Development to Dow Pharmaceutical Sciences, May 4, 2009 Other Letter(s) 2009-05-05T04:00:00Z 2009 5 2009-05-05T04:00:00Z   2015-05-05T19:24:17Z   0 0 090000648097603d
FDA-1996-N-0006-0077 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to RJR Consulting, Inc., May 4, 2009 Other Letter(s) 2009-05-05T04:00:00Z 2009 5 2009-05-05T04:00:00Z   2015-05-05T19:28:13Z   0 0 090000648097603f
FDA-1996-N-0006-0071 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to 3V, Inc., May 4, 2009 Other Letter(s) 2009-05-05T04:00:00Z 2009 5 2009-05-05T04:00:00Z   2015-05-05T19:13:03Z   0 0 0900006480976039
FDA-1996-N-0006-0072 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to CIBA Specialty Chemicals Corporation, May 4, 2009 Other Letter(s) 2009-05-05T04:00:00Z 2009 5 2009-05-05T04:00:00Z   2015-05-05T19:16:57Z   0 0 090000648097603a
FDA-1996-N-0006-0069 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to L'Oreal USA Products R&D, May 4, 2009 Other Letter(s) 2009-05-05T04:00:00Z 2009 5 2009-05-05T04:00:00Z   2015-05-05T19:05:01Z   0 0 0900006480976037
FDA-1996-N-0006-0073 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Consumer Healthcare Products Association (CHPA), May 4, 2009 Other Letter(s) 2009-05-05T04:00:00Z 2009 5 2009-05-05T04:00:00Z   2015-05-05T19:20:57Z   0 0 090000648097603b
FDA-1996-N-0006-0066 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Ropes & Gray, LLP, May 4, 2009 Other Letter(s) 2009-05-05T04:00:00Z 2009 5 2009-05-05T04:00:00Z   2015-05-05T18:53:34Z   0 0 0900006480975db2
FDA-1996-N-0006-0074 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Parexel International, May 4, 2009 Other Letter(s) 2009-05-05T04:00:00Z 2009 5 2009-05-05T04:00:00Z   2015-05-05T19:22:46Z   0 0 090000648097603c
FDA-1996-N-0006-0058 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Morgan, Lewis & Bockius, LLP Other Letter(s) 2009-04-16T04:00:00Z 2009 4 2009-04-16T04:00:00Z   2015-05-05T18:41:16Z   0 0 090000648095735a
FDA-1996-N-0006-0055 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to CIBA Specialty Chemicals Corporation Other Letter(s) 2009-04-16T04:00:00Z 2009 4 2009-04-16T04:00:00Z   2015-05-05T18:36:15Z   0 0 090000648095725e
FDA-1996-N-0006-0056 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Buchanan Ingersoll Other Letter(s) 2009-04-16T04:00:00Z 2009 4 2009-04-16T04:00:00Z   2015-05-05T18:38:09Z   0 0 0900006480957293
FDA-1996-N-0006-0052 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to 3V, Inc. Other Letter(s) 2009-04-16T04:00:00Z 2009 4 2009-04-16T04:00:00Z   2015-05-05T18:30:48Z   0 0 09000064809571c2
FDA-1996-N-0006-0062 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from Steinberg & Associates, Inc. to FDA/CDER Questions Other Letter(s) 2009-04-16T04:00:00Z 2009 4 2009-04-16T04:00:00Z   2015-05-05T18:03:20Z   0 0 0900006480957545
FDA-1996-N-0006-0051 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Parexel International Other Letter(s) 2009-04-16T04:00:00Z 2009 4 2009-04-16T04:00:00Z   2015-05-05T18:28:40Z   0 0 0900006480957156
FDA-1996-N-0006-0049 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to The Personal Care Products Council Other Letter(s) 2009-04-16T04:00:00Z 2009 4 2009-04-16T04:00:00Z   2015-05-05T18:24:11Z   0 0 0900006480956ede
FDA-1996-N-0006-0061 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Steinberg & Associates, Inc. Other Letter(s) 2009-04-16T04:00:00Z 2009 4 2009-04-16T04:00:00Z   2015-05-05T18:46:23Z   0 0 090000648095744d
FDA-1996-N-0006-0053 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Dow Pharmaceutical Sciences Other Letter(s) 2009-04-16T04:00:00Z 2009 4 2009-04-16T04:00:00Z   2015-05-05T18:32:36Z   0 0 0900006480957206
FDA-1996-N-0006-0059 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Ropes & Gray, LLP Other Letter(s) 2009-04-16T04:00:00Z 2009 4 2009-04-16T04:00:00Z   2015-05-05T18:43:16Z   0 0 09000064809573e1
FDA-1996-N-0006-0057 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to L'Oreal USA Products R&D Other Letter(s) 2009-04-16T04:00:00Z 2009 4 2009-04-16T04:00:00Z   2015-05-05T18:39:36Z   0 0 09000064809572ff
FDA-1996-N-0006-0050 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to RJR Consulting, Inc. Other Letter(s) 2009-04-16T04:00:00Z 2009 4 2009-04-16T04:00:00Z   2015-05-05T18:26:52Z   0 0 0900006480956f1d
FDA-1996-N-0006-0054 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Keller and Heckman, LLP Other Letter(s) 2009-04-16T04:00:00Z 2009 4 2009-04-16T04:00:00Z   2015-05-05T18:34:24Z   0 0 0900006480957233
FDA-1996-N-0006-0060 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Consumer Healthcare Products Association (CHPA) Other Letter(s) 2009-04-16T04:00:00Z 2009 4 2009-04-16T04:00:00Z   2015-05-05T18:44:54Z   0 0 0900006480957423
FDA-1996-N-0006-0048 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Additional Conditions in the Over-the-Counter Drug Monograph System - Time and Extent Application (TEA) Process; Request for Information and Questions; Extension of Deadline for Submissions Other Letter(s) 2009-04-16T04:00:00Z 2009 4 2009-04-16T04:00:00Z 2009-05-01T03:59:59Z 2015-05-05T18:21:11Z   0 0 0900006480954d7f
FDA-1996-N-0006-0041 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Ropes & Gray, LLP Other Letter(s) 2009-04-14T04:00:00Z 2009 4 2009-04-14T04:00:00Z   2015-05-05T15:50:55Z   0 0 0900006480953826
FDA-1996-N-0006-0040 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Morgan, Lewis & Bockius, LLP Other Letter(s) 2009-04-14T04:00:00Z 2009 4 2009-04-14T04:00:00Z   2015-05-05T14:31:23Z   0 0 090000648095381d
FDA-1996-N-0006-0028 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Additional Conditions in the Over-the-Counter Drug Monograph System - Time and Extent Application (TEA) Process; Request for Information and Questions Other Letter(s) 2009-04-14T04:00:00Z 2009 4 2009-03-25T04:00:00Z 2009-04-16T03:59:59Z 2015-03-21T23:15:06Z   0 0 0900006480953243
FDA-1996-N-0006-0030 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to RJR Consulting, Inc. Other Letter(s) 2009-04-14T04:00:00Z 2009 4 2009-04-14T04:00:00Z   2015-03-23T14:50:02Z   0 0 0900006480953663
FDA-1996-N-0006-0038 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Sue Ismiel & Daughters US, Inc Other Letter(s) 2009-04-14T04:00:00Z 2009 4 2009-04-14T04:00:00Z   2015-06-25T17:02:09Z   0 0 0900006480953801
FDA-1996-N-0006-0045 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from Ciba Corporation to FDA/CDER Questions Other Letter(s) 2009-04-14T04:00:00Z 2009 4 2009-04-14T04:00:00Z   2015-05-05T18:00:11Z   0 0 0900006480953612
FDA-1996-N-0006-0029 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to The Personal Care Products Council Other Letter(s) 2009-04-14T04:00:00Z 2009 4 2009-04-14T04:00:00Z   2015-03-23T14:41:34Z   0 0 0900006480953641
FDA-1996-N-0006-0031 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Parexel International Other Letter(s) 2009-04-14T04:00:00Z 2009 4 2009-04-14T04:00:00Z   2015-05-05T13:57:13Z   0 0 090000648095377d
FDA-1996-N-0006-0042 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Consumer Healthcare Products Association (CHPA) Other Letter(s) 2009-04-14T04:00:00Z 2009 4 2009-04-14T04:00:00Z   2015-05-05T17:58:25Z   0 0 0900006480953851
FDA-1996-N-0006-0037 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Symrise Other Letter(s) 2009-04-14T04:00:00Z 2009 4 2009-04-14T04:00:00Z   2015-05-05T14:14:40Z   0 0 09000064809537f3
FDA-1996-N-0006-0039 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to L'Oreal USA Products R&D Other Letter(s) 2009-04-14T04:00:00Z 2009 4 2009-04-14T04:00:00Z   2015-06-25T17:03:14Z   0 0 090000648095380f
FDA-1996-N-0006-0046 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from Consumer Healthcare Products Association (CHPA) to FDA/CDER Questions Other Letter(s) 2009-04-14T04:00:00Z 2009 4 2009-04-14T04:00:00Z   2015-05-05T18:01:50Z   0 0 090000648095293d
FDA-1996-N-0006-0032 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to 3V, Inc. Other Letter(s) 2009-04-14T04:00:00Z 2009 4 2009-04-14T04:00:00Z   2015-05-05T13:57:36Z   0 0 09000064809537a4
FDA-1996-N-0006-0047 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from Morgan, Lewis & Bockius, LLP to FDA/CDER Questions Other Letter(s) 2009-04-14T04:00:00Z 2009 4 2009-04-14T04:00:00Z   2015-03-20T19:24:24Z   0 0 09000064809538ba
FDA-1996-N-0006-0043 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from 3V, Inc. Other Letter(s) 2009-04-14T04:00:00Z 2009 4 2009-04-14T04:00:00Z   2015-05-05T17:59:31Z   0 0 090000648095375c
FDA-1996-N-0006-0033 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Dow Pharmaceutical Sciences Inc. Other Letter(s) 2009-04-14T04:00:00Z 2009 4 2009-04-14T04:00:00Z   2015-05-05T13:57:59Z   0 0 09000064809537b5
FDA-1996-N-0006-0036 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Buchanan Ingersoll Other Letter(s) 2009-04-14T04:00:00Z 2009 4 2009-04-14T04:00:00Z   2015-05-05T14:11:35Z   0 0 09000064809537e4
FDA-1996-N-0006-0034 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to Keller and Heckman, LLP Other Letter(s) 2009-04-14T04:00:00Z 2009 4 2009-04-14T04:00:00Z   2015-05-05T14:01:18Z   0 0 09000064809537c8
FDA-1996-N-0006-0035 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Letter from FDA/CDER Division of Nonprescription Regulation Development to CIBA Specialty Chemicals Corporation Other Letter(s) 2009-04-14T04:00:00Z 2009 4 2009-04-14T04:00:00Z   2015-05-05T14:09:14Z   0 0 09000064809537d6
FDA-1996-N-0006-0044 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 See FDA-1996-N-0006-0062 Supporting & Related Material   2009-04-14T00:00:00Z 2009 4     2009-04-17T04:08:16Z   0 1 09000064809535ba

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);